Podcast Episodes

Back to Search
Future Treatment Strategies for Acute Myeloid Leukemia—Emerging Targeted Therapy Combinations and Beyond

Future Treatment Strategies for Acute Myeloid Leukemia—Emerging Targeted Therapy Combinations and Beyond


Episode 6


In this episode, Naval G. Daver, MD, discusses promising investigational agents and treatment combinations in clinical trials for patients with newly diagnosed and relapsed/refractory AML, including:…


Published on 5 years, 2 months ago

Tumor Agnostic TRK Inhibitor Therapy and NTRK Fusion Testing: Experts Answer Clinician Questions

Tumor Agnostic TRK Inhibitor Therapy and NTRK Fusion Testing: Experts Answer Clinician Questions


Episode 5


In this episode, George D. Demetri, MD; Alexander Drilon, MD; and Pashtoon Kasi, MD, answer questions about NTRK fusion testing and TRK inhibitor therapy for patients with advanced solid tumors, with…


Published on 5 years, 2 months ago

Improving Outcomes for Patients With CML With TKIs: FAQ Podcast

Improving Outcomes for Patients With CML With TKIs: FAQ Podcast


Episode 4


In this episode, Prof. Dr. med Tim Henrik Brümmendorf; Jorge Cortes, MD; and Carlo Gambacorti-Passerini, MD, answer questions focused on the optimal selection and management of tyrosine kinase inhibi…


Published on 5 years, 2 months ago

Application of Existing and Emerging Biomarkers for Immuno-Oncology Across Tumor Types: Answering Clinician Questions

Application of Existing and Emerging Biomarkers for Immuno-Oncology Across Tumor Types: Answering Clinician Questions


Episode 1


In this episode, an expert medical oncology panel led by John L. Marshall, MD, with Jamie E. Chaft, MD, and Scot Niglio, MD, provides a brief overview on the revolutionary changes brought by immuno-o…


Published on 5 years, 2 months ago

Precision Therapy in Lung Cancer: FAQ on Biomarker Testing and Targeted Therapies

Precision Therapy in Lung Cancer: FAQ on Biomarker Testing and Targeted Therapies


Episode 2


In this episode, Edward S. Kim, MD, FACP, and Leora Horn, MD, MSc, FRCPC, answer questions focused on biomarker testing and selecting targeted therapy for patients with advanced non-small-cell lung c…


Published on 5 years, 2 months ago

Precision Therapy in Lung Cancer: FAQ on Biomarkers for Immune Checkpoint Inhibitors

Precision Therapy in Lung Cancer: FAQ on Biomarkers for Immune Checkpoint Inhibitors


Episode 3


In this episode, Edward S. Kim, MD, FACP, and Leora Horn, MD, MSc, FRCPC, answer questions focused on current and evolving biomarkers for immune checkpoint inhibitor–based therapies in advanced non-s…


Published on 5 years, 2 months ago





If you like Podbriefly.com, please consider donating to support the ongoing development.

Donate